Mild or Intermediate Symptomatic Carotid Lesions: What we need to know about plaque

Ischemic stroke is the main reason behind disability in the world, and it is often followed by death. 

Carotídeas asintomáticas ¿Tenemos todas las respuestas?

The rupture of carotid atherosclerotic plaque and its embolization are the main cause of this entity. 

Different randomized studies have shown that carotid endarterectomy is beneficial in symptomatic patients with 70 to 99% carotid obstruction, but we still need to find evidence to establish the best treatment for mild and intermediate lesions. 

The PARISK study, an observational multicenter prospective trial, included 238 patients with a history of transient ischemic attack (TIA)  or monocular stroke, TIA or minor carotid stroke with mild to moderate ipsilateral carotid lesion. 

Patients were looked at using magnetic resonance imaging (MRI) and computed tomography angiography (AngioTAC) to look at four carotid plaque properties: presence of intraplaque hemorrhage (MRI), (ulceration (AngioTAC), proportion of calcifications (AngioTAC), and total plaque volume (MRI). 

Read also: Symptomatic Carotid Arteries: Early or Late Emergency Revascularization?

Mean age was 69, 71% were men, 86% were hypertensive, 26% diabetic, 49% had a history of myocardial ischemia.

45% presented TIA, 44% stroke and 111% stroke or monocular TIA.

Carotid obstruction (ECST risk score) was 0 to 30% in 73% of patients, 30 to 49% in 23%, and 50 to 69% in the remaining 4%.  

There was 39% intraplaque hemorrhage, 27% ulceration, 7.3% calcification and 1281.5 µL total plaque volume. 

Read also: Asymptomatic Carotid Lesions and Cognitive Impairment: Does Intervention Play a Role?

At 5 year-followup TIA or stroke was associated to presence and total volume of intraplaque hemorrhage (HR: 2.12 [95% CI: 1.02-4.44] for IPH; HR: 1.07 [95% CI: 1.00-1.15] for total plaque volume per 100 µL increase).

Ulcerations and calcifications were not associated to events. 

Conclusion

Intraplaque hemorrhage and total plaque volume are independent risk factor of TIA or recurrent ipsilateral stroke in patients with mild to moderate carotid stenosis. Plaque characteristics will improve decision making. Further study is required to validate plaque characteristics and its implementation in clinical scores. 

Dr. Carlos Fava - Consejo Editorial SOLACI

Dr. Carlos Fava.
Member of the Editorial Board of SOLACI.org.

Original Title: Carotid Plaque Characteristics Predict Recurrent Ischemic Stroke and TIA. The PARISK (Plaque At RISK) Study.

Reference: Dianne H.K. van Dam-Nolen, et a. J Am Coll Cardiol Img 2022;15:1715–1726.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Therapeutic strategies in carotid free-floating thrombus: evidence and controversies

Carotid free-floating thrombus (cFFT) is a rare entity with a high embolic risk, associated with acute neurological events such as stroke or transient ischemic...

ACC 2026 | SirPAD Trial: Sirolimus-coated balloon angioplasty in infrainguinal arterial disease

Paclitaxel-coated balloons have demonstrated improved patency in peripheral arterial disease (PAD), although questions remain regarding safety and applicability across different vascular territories. In this...

ACC 2026 | HI-PEITHO: Catheter-directed strategy (EKOS) in intermediate-risk acute pulmonary embolism

The treatment of intermediate-risk pulmonary embolism (PE) continues to be an area of therapeutic uncertainty. The initial PEITHO study (2014) demonstrated a reduction in...

ACVC 2026 | FLASH Registry European Cohort: Mechanical Thrombectomy in Pulmonary Embolism

The management of intermediate-high and high-risk pulmonary embolism (PE) remains an area of therapeutic uncertainty, particularly in patients with right ventricular (RV) dysfunction, in...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

High Ischaemic Risk Criteria in Chronic Coronary Syndrome: Prevalence and Prognosis

Despite advances in the management of chronic coronary syndrome (CCS), including the widespread use of drug-eluting stents (DES) and the optimization of medical therapy,...

Management of Valve Thrombosis in TAVI: Current Evidence-Based Approach

The expansion of transcatheter aortic valve implantation (TAVI) into younger and lower-risk populations has brought bioprosthetic valve thrombosis to the forefront as a clinically...

Experience with the intra-annular self-expanding Navitor valve: data from the STS/ACC TVT registry

The expansion of TAVI, with the introduction of new-generation devices, has prioritized not only periprocedural safety, but also the preservation of coronary access, more...